BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:46 PM
 | 
May 27, 2008
 |  BC Extra  |  Company News

Europe approves Novartis' Extavia

The European Commission approved an MAA for Extavia interferon beta-1b from Novartis (NYSE:NVS; SWX:NOVN) to treat early and relapsing...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >